Insmed Inc. Surges to All-Time High on Optimistic Outlook

viernes, 31 de octubre de 2025, 10:08 am ET1 min de lectura
INSM--

Insmed Inc. (NASDAQ:INSM) reached an all-time high after posting a highly optimistic outlook for the full-year period, despite a widening net loss in Q3. The company expects global revenues from Arikayce to grow between 15-18% to $420-$430 million, up from a previous projection of $405-$425 million. Revenues from Arikayce grew 22% YoY to $114.3 million, and Brinspuri generated $28.1 million in revenues during the quarter. The stock soared 16.33% to $194.22 per share.

Insmed Inc. Surges to All-Time High on Optimistic Outlook

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios